@kiny, thank you for posting as always. You may not know but the insight you bring here is the silver lining to many of us. I have tried EEN myself and it’s definitely legit - more than one time saved me from surgery and complications. When it comes to the management of ileal CD, EN has efficacy that is superior to all other existing treatments, even combined immunosuppressants/biologics. The evidence is overwhelming.
But sadly, it still isn't the best option. It's just the sharpest knife in the rust. Inflammation would come back after food reintroduction. Straight adherence is not easy.
That being said, more seem to be under the hood for EN.
There have been studies and echo to what you've posted the other day that a prolonged course of EEN (16+ weeks) may result in better healing:
Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study
Oral exclusive enteral nutrition induces mucosal and transmural healing in patients with Crohn's disease
Also, cyclically go through exclusive periods of EN vs normal food intake is a better maintenance strategy than mixed, partial EN:
Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study
This "exclusiveness" is important as it keeps the bowel away from further damages and gives time for the intestine to replenish itself.
Jean-Frédéric Colombel in a recent interview also pointed out that a subset of the patients have achieved sustained remission after surgery. This aligns with what we hear from the CD veterans, some now in their 50-60s already enjoyed years of symptom free remission post-surgery:
These all make me wonder if there exist a "tipping point" if we want to achieve deep remission and eventually change the disease's progression? If the disease isn't controlled up until such point, inflammation would easily come back when antigens are present - and you can't do EN a lifetime.
If so, do weapons in our current medical arsenal (TNF-a / IL-23 antagonists etc.), combined with EN, sufficient to bring us across that chasm? In other words, is deep, histological and biomolecular remission an achievable goal now?